Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YU0L
|
|||
| Drug Name |
GPA-TriMAR-T cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
Timmune Biotech Inc.
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Gp100[209-217] peptide (PMEL) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03649529) Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.